Werkgroep Cardiologische centra Nederland

PACIFIC-AMI (Recruiting)

Randomized, placebo controlled, double-blind, parallel group, dose-finding Phase 2 study to evaluate the efficacy and safety of the oral FXIa inhibitor BAY 2433334 in patients following ACS
Medicine
FXIa inhibitor BAY 2433334
Population
ASCVD
Phase
II
Starting year
2019

Director of Study

dr. R.S. Hermanides (Cardioloog)
Zwolle, Isala Zwolle